Estrigenix Therapeutics, Inc.
Wauwatosa, WI
- UEI
- T25FLAVQHKP5
- CAGE
- 8ESQ4
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1225 Discovery Pkwy 255 c, Wauwatosa, WI 53226, USA
- Website
- estrigenix.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of EGX358, an ER-beta agonist to treat hot flashes & menopause-related memory loss - there are >60… | National Institute on Aging (NIH) | $598,112 |
Quick answers
Is Estrigenix Therapeutics, Inc. registered in SAM.gov?
Yes. Estrigenix Therapeutics, Inc.'s SAM.gov registration is active through July 8, 2027.
What is Estrigenix Therapeutics, Inc.'s most recent federal award?
Estrigenix Therapeutics, Inc.'s most recent federal grant award is Development of EGX358, an ER-beta agonist to treat hot flashes & menopause-related memory loss - there are >60… (R43AG079715), from National Institute on Aging (NIH), on September 15, 2022.
On GovTribe
See Estrigenix Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors